When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. FDA approves opioid-free pain medication with 'no sign of ...

   www.aol.com/fda-approves-opioid-free-pain...

   A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...

3. List of methylphenidate analogues - Wikipedia

   en.wikipedia.org/wiki/List_of_methylphenidate...

   3D molecular rendering of methylphenidate (MPH). This is a list of methylphenidate (MPH or MPD) analogues, or Phenidates.The most well known compound from this family, methylphenidate, is widely prescribed around the world for the treatment of attention deficit hyperactivity disorder (ADHD) and certain other indications.

4. FDA approves new pain medication as an alternative to ... - AOL

   www.aol.com/news/fda-approves-pain-medication...

   For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

5. Methylphenidate - Wikipedia

   en.wikipedia.org/wiki/Methylphenidate

   Methylphenidate, sold under the brand names Ritalin (/ ˈ r ɪ t ə l ɪ n / RIT-ə-lin) and Concerta (/ k ə n ˈ s ɜːr t ə / kən-SUR-tə) among others, is a central nervous system (CNS) stimulant indicated in the pharmacotherapy of attention deficit hyperactivity disorder (ADHD) and narcolepsy.

6. Analgesic adjuvant - Wikipedia

   en.wikipedia.org/wiki/Analgesic_adjuvant

   An analgesic adjuvant is a medication that is typically used for indications other than pain control but provides control of pain in some painful diseases. This is often part of multimodal analgesia, where one of the intentions is to minimize the need for opioids. [1] [2] [3]

7. Experimental pain drug may offer alternative to opioids for ...

   www.aol.com/experimental-pain-drug-may-offer...

   On a different measure, the Numeric Pain Rating Scale, VX-548 and the opioid comparator showed similar reductions: 47% and 43%, respectively, in abdominoplasty patients, who started at an average ...